← FDA DRUG APPROVALS

FDA ANDA · ANDA211309

METFORMIN HYDROCHLORIDE ORAL SOLUTION

metformin hydrochloride

Sponsor: SAPTALIS PHARMS

APPLICATION
ANDA211309
TYPE
ANDA
ORIGINAL APPROVAL
2020-03-03
LATEST ACTION
2024-12-11
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Prescription

Products

METFORMIN HYDROCHLORIDEPrescription
METFORMIN HYDROCHLORIDE 500MG/5ML · SOLUTION · ORAL

Approval history

2024-12-11Labeling · Supplement 9 · standardAP
2020-03-03UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →